Castleark Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-96,045
| Closed | -$4.66M | – | 344 |
|
|
2020
Q2 | $4.66M | Sell |
96,045
-117,025
| -55% | -$5.67M | 0.2% | 129 |
|
|
2020
Q1 | $9M | Sell |
213,070
-2,700
| -1% | -$114K | 0.53% | 52 |
|
|
2019
Q4 | $9.23M | Buy |
215,770
+23,700
| +12% | +$1.01M | 0.37% | 88 |
|
|
2019
Q3 | $6.91M | Buy |
+192,070
| New | +$6.91M | 0.28% | 126 |
|
|
2017
Q2 | – | Sell |
-206,980
| Closed | -$7.12M | – | 389 |
|
|
2017
Q1 | $7.12M | Buy |
+206,980
| New | +$7.12M | 0.22% | 149 |
|